Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Martin Åmark, CEO for Xbrane Biopharma AB, becomes Head of IR for the Company | ||
By: Nasdaq / GlobeNewswire - 14 Feb 2019 | Back to overview list |
|
Press release Martin Åmark, CEO of Xbrane Biopharma AB ("Xbrane"), will as of today also be the Head of IR for Xbrane. The reason for this is that Xbrane's current Head of IR and CFO, Susanna Helgesen, will be on parental leave on a part-time basis for a period. During the parental leave, Susanna Helgesen will remain as CFO. The finance team has also been expanded with a Group Financial Controller. For further information, please contact: Susanna Helgesen About Xbrane Attachment |
||
|
||
Copyright 2019 Nasdaq / GlobeNewswire | Back to overview list |